We have received funding from the CRI for a novel study!

Dr. Marcin Cieslik (PI) and I (Co-I) have received the Technology Impact Award from Cancer Research Institute to develop a novel method for spatially and clonally resolved profiling of tumor-infiltrating lymphocytes. Thank you CRI for the support- we are excited to kick off this study with potential impact on cancer immunotherapy!